Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The record history now includes a newer revision (v3.6.3) replacing the previous revision (v3.6.2), indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-07-03T22:00:13.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Footer area expanded with additional site-wide links and policy text, representing a system-wide footer update rather than changes to the study content.
    Difference
    31%
    Check dated 2026-06-26T19:49:36.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The study record history now shows two Results Submission Events instead of one, indicating an additional results submission event reflected in the history.
    Difference
    0.1%
    Check dated 2026-06-19T17:47:50.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The study record now shows that no participants are being sought, updating the recruitment status. A new revision tag, v3.6.0, has been added to the history to reflect an updated record version.
    Difference
    0.4%
    Check dated 2026-06-12T13:25:16.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The record history now shows a new revision (v3.5.5) replacing the prior v3.5.4. This indicates an updated version of the study record in ClinicalTrials.gov history.
    Difference
    0.1%
    Check dated 2026-06-05T10:18:56.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A new Results Submission Events (1) entry appears in the Record History, and the revision is updated from v3.5.3 to v3.5.4 to reflect the latest version of the study record.
    Difference
    0.3%
    Check dated 2026-05-15T02:16:34.000Z thumbnail image

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.